USANA Health Sciences Inc

USANA Health Sciences Inc

Consumer Staples Food Producers
  • Price (USD)62.48
  • Today's Change0.01 / 0.02%
  • Shares traded1.00
  • 1 Year change-21.35%
  • Beta0.7694
Data delayed at least 15 minutes, as of Mar 30 2023 21:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

USANA Health Sciences, Inc. develops and manufactures nutritional supplements, functional foods, and personal care products. The Company’s product line includes USANA Nutritionals Essentials/CellSentials, optimizers, foods, skincare, and all other. It also manufactures and sells protein bars. It provides a personal development framework that helps individuals create a life of balance, growth, and purpose. Its USANA Nutritionals Essentials/CellSentials includes vitamin and mineral supplements that provides a total body nutrition for every age group beginning with children 13 months of age. Its optimizers include supplements designed to meet individual health and nutritional needs. Its food product line includes meal replacement shakes, snack bars, and other related products that provide macro-nutrition. Its all-other product line includes materials and online tools that are designed to assist its associates in building their businesses and in marketing its products.

  • Revenue in USD (TTM)998.60m
  • Net income in USD69.35m
  • Incorporated1992
  • Employees1.90k
  • Location
    USANA Health Sciences Inc3838 W Parkway BlvdSALT LAKE CITY 84120-6336United StatesUSA
  • Phone+1 (801) 954-7100
  • Fax+1 (801) 956-9486
  • Websitehttps://www.usana.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
USNA:NYQ since
Oola Global LLCDeal completed28 Nov 202228 Nov 2022Deal completed18.07%--
Rise BarDeal completed28 Nov 202228 Nov 2022Deal completed18.07%--
Data delayed at least 15 minutes, as of Mar 30 2023 21:10 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Scilex Holding Co0.001.76m1.12bn2.0060.611.14----0.12720.12720.006.780.00----0.001.46--1.46--------------0.00------12,575.16------
Deciphera Pharmaceuticals Inc134.04m-178.93m1.13bn300.00--2.97--8.45-2.55-2.551.885.050.30340.50576.23446,786.70-40.50-44.40-51.10-50.9493.46---133.49-349.014.31--0.00--39.41--40.35--15.68--
Summit Therapeutics Inc705.00k-78.78m1.14bn76.00--2.72--1,613.09-0.6299-0.62990.00520.6000.0018--0.77779,276.32-20.26-31.37-22.09-36.78-----11,174.75-391.00---7.390.8024---61.03-46.5111.08---5.36--
Avid Bioservices Inc140.69m116.47m1.14bn321.0014.,295.9030.4712.5238.8317.8621.3719.4082.7826.880.99911.650.43470.0024.7515.723,747.86--73.13--
MoonLake Immunotherapeutics0.00-64.51m1.15bn----23.55-----1.88-1.880.000.92780.00-------66.96---79.99--------------0.00-------1,320.01------
Protagonist Therapeutics Inc26.58m-127.39m1.15bn105.00--5.15--43.38-2.60-2.600.5424.370.0893--12.05253,152.40-42.78-37.12-48.96-43.97-----479.26-382.69----0.00---2.845.79-1.47--3.60--
Avidity Biosciences Inc9.22m-174.00m1.19bn186.00--2.03--128.97-3.33-3.330.17698.290.0173----49,591.40-32.63---35.34-------1,886.33------0.00---1.09---47.44------
Prime Medicine Inc0.00-142.01m1.19bn175.00--3.77-----1.46-1.460.003.250.00----0.00-36.79---42.19-------------14.340.00------22.87------
Keros Therapeutics Inc0.00-104.68m1.20bn105.00--4.18-----4.15-4.150.0010.070.00----0.00-37.25---39.23-------------114,790.000.00---100.00---78.20------
USANA Health Sciences, Inc.998.60m69.35m1.21bn1.90k17.412.7614.571.213.593.5951.7122.621.702.34--525,579.5011.8118.8715.9525.6880.5881.886.949.652.21--0.000.00-15.83-0.9471-40.47-5.635.07--
Adaptive Biotechnologies Corp185.31m-200.19m1.21bn790.00--2.60--6.51-1.41-1.411.303.240.20823.446.45234,567.10-22.51-17.18-25.75-19.0768.7570.34-108.13-115.584.99-1,091.130.00--20.0636.963.42--45.51--
Ligand Pharmaceuticals Inc196.25m-5.22m1.22bn76.00--2.0326.336.21-0.3131-1.9811.5935.250.19052.603.392,582,171.00-0.506613.41-0.543714.3773.0884.19-2.6679.702.53--0.1138---29.196.82-109.13--52.74--
Dynavax Technologies Corp722.68m292.87m1.23bn351.004.962.124.151.711.941.944.804.550.71374.345.532,058,926.0028.95-0.678944.46-1.0163.7360.8040.56-1.355.71--0.2761--64.45366.53305.96--60.56--
Recursion Pharmaceuticals Inc39.84m-239.48m1.23bn500.00--2.26--30.96-1.37-1.370.2272.850.0608--2,343.7179,686.00-36.52---41.12---21.16---601.05------0.0013--291.46---28.42------
Agios Pharmaceuticals Inc14.24m-231.80m1.25bn389.00--1.13--87.55-4.24-4.240.259920.000.0106--4.3336,606.68-17.32-31.51-18.15-34.4288.03---1,627.82-1,440.7613.16--0.00-----19.8334.98--1.07--
Arcus Biosciences Inc112.00m-267.00m1.27bn500.00--1.94--11.38-3.71-3.711.569.010.0763--0.2851224,000.00-18.18-13.06-20.72-14.82-----238.39-79.12----0.00---70.75139.78-605.39--1.70--
Data as of Mar 30 2023. Currency figures normalised to USANA Health Sciences Inc's reporting currency: US Dollar USD

Institutional shareholders

37.29%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 31 Dec 20221.76m9.17%
The Vanguard Group, Inc.as of 31 Dec 20221.50m7.84%
Renaissance Technologies LLCas of 31 Dec 20221.22m6.38%
Pzena Investment Management LLCas of 31 Dec 2022716.88k3.73%
Dimensional Fund Advisors LPas of 31 Dec 2022551.48k2.87%
SSgA Funds Management, Inc.as of 31 Dec 2022425.28k2.21%
Acadian Asset Management LLCas of 31 Dec 2022368.32k1.92%
Geode Capital Management LLCas of 31 Dec 2022225.96k1.18%
Invesco Capital Management LLCas of 31 Dec 2022192.65k1.00%
Charles Schwab Investment Management, Inc.as of 31 Dec 2022189.44k0.99%
More ▼
Data from 31 Dec 2022 - 31 Dec 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.